Call for Papers for 2011
"PROMISING NEW INVESTIGATORS
TRAVEL SCHOLARSHIP”

The Neuroleptic Malignant Syndrome Information Service (NMSIS) is pleased to announce a competition to recognize promising new investigators based on a scholarly paper addressing "New insights on psychotropic drug safety and side effects".

Consistent with its mission to advance pharmacotherapy and patient safety, NMSIS offers these scholarships to promote education and research by early career psychiatrists.

Two prizes of $2000 and $1000 are meant to help cover travel costs to the American Psychiatric Association (APA) Annual Meeting in Hawaii. in May 2011.  The scholarships will be presented during the APA event so that the recipients can attend the educational sessions and workshops that are vital to their professional careers.

· Papers should address specific issues related to the award theme and be no longer than 15 double-spaced typed pages in length.

· Literature reviews, case reports, or original studies that are not in press or published are acceptable.

· Primary author must be a student, resident or fellow.
· Papers will be judged on originality, scholarship, relevance and methodology.

The past three years’ recipients of the monetary prizes were:

Angelica Kloos D.O., Children's National Medical Center, Washington, DC, 1st Place 2010
Robert O. Cotes, M.D., Dartmouth-Hitchcock Medical Center, 2nd Place 2010

Dr. Josephine Mokonogho, University of Ibadan, Nigeria, 1st Place, 2009
Dr. Matthew Prowler, Jefferson Medical College, Philadelphia, PA, 2nd Place 2009

Dr. Martin Strassnig, University of Pittsburg Medical Center, 1st Place 2008
Dr. Lauren Shin, Cambridge Hospital, Harvard Medical School, 2nd Place 2008

To participate, papers and curriculum vitae of the primary author must be submitted by February 6th, 2011 to the attention of Ms. Dianne Daugherty, NMSIS, 11 East State Street, Sherburne, NY 13460, fax 607-674-7910, or via email to info@nmsis.org.  Winners will be announced on March 6th, 2011.

Supported by an educational grant from Janssen, L.P., administered by Ortho-McNeil Janssen Scientific Affairs, LLC